- Consumer Products
- Latest 122.26
- Currency US$
- Change -1.93
- Percent Change -1.554 %
- Volume 7,124,965
- Fri Mar 7, 2014 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jan 28||$1.64||Apr 22||$1.81|
12 months ended Mar 07, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.